Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
-1,49%
1 075,22
-16,29
-1,49%
—1 091,511 090,401 090,401 074,65——
SIXC
Communications
SIXC
Communications
SIXC
-0,36%
607,92
-2,19
-0,36%
—610,11610,11610,29606,17——
SIXE
Energy
SIXE
Energy
SIXE
+0,78%
1 247,62
+9,64
+0,78%
—1 237,981 237,831 252,411 225,03——
SIXI
Industrials
SIXI
Industrials
SIXI
-1,13%
1 724,96
-19,75
-1,13%
—1 744,711 740,951 747,291 721,57——
SIXM
Financials
SIXM
Financials
SIXM
-0,73%
635,51
-4,67
-0,73%
—640,18639,92643,19634,73——
SIXR
Staples
SIXR
Staples
SIXR
-1,17%
839,60
-9,98
-1,17%
—849,58845,27851,68839,47——
SIXRE
Real estate
SIXRE
Real estate
SIXRE
-0,85%
215,63
-1,85
-0,85%
—217,48217,48218,16215,51——
SIXT
Technology
SIXT
Technology
SIXT
+0,14%
3 265,18
+4,49
+0,14%
—3 260,693 273,363 287,813 240,78——
SIXU
Utilities
SIXU
Utilities
SIXU
-0,77%
935,24
-7,21
-0,77%
—942,45939,39948,80933,98——
SIXV
Health care
SIXV
Health care
SIXV
-0,23%
1 463,38
-3,42
-0,23%
—1 466,801 464,701 467,191 458,36——
SIXY
Discretionary
SIXY
Discretionary
SIXY
-0,79%
2 378,64
-18,86
-0,79%
—2 397,502 395,032 412,012 370,64——
NEU:ASX
Neuren Pharmaceuticals Ltd
A$12,60
+1,04%
(+0,13) 1D
4 Mei, 16:10:20 GMT+10  ·   AUD
All symbols
SymbolPriceChange% Change
Generating top insights for NEU...
Open
A$12,55
High
A$12,77
Low
A$12,26
Mkt. cap
1,59 mjd
Avg. vol.
424,97 k
Volume
203,31 k
P/E ratio
54,14
52-wk high
A$22,98
52-wk low
A$11,00
EPS
A$0,23
Shares outstanding
126,50 m
No. of employees
8
News stories
From sources across the web
About Neuren Pharmaceuticals Ltd
CEOJon Pilcher
Employees8
Founded2001
Headquarters-
SectorPharmaceutical industry
Websiteneurenpharma.com
Previous reportsAll values in AUD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in AUD
Mrt. 2025
Jun. 2025
Sep. 2025
Des. 2025
Revenue
14,14 m
14,14 m
18,19 m
18,19 m
Cost of goods sold
7,45 m
7,45 m
10,75 m
10,75 m
Cost of revenue
7,45 m
7,45 m
10,75 m
10,75 m
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1,24 m
1,24 m
1,87 m
1,87 m
Operating expense
1,24 m
1,24 m
1,87 m
1,87 m
Total operating expenses
8,69 m
8,69 m
12,62 m
12,62 m
Operating income
5,45 m
5,45 m
5,57 m
5,57 m
Other non operating income
-1,31 m
-1,31 m
-337,50 k
-337,50 k
EBT including unusual items
9,86 m
9,86 m
9,60 m
9,60 m
EBT excluding unusual items
9,86 m
9,86 m
9,60 m
9,60 m
Income tax expense
2,34 m
2,34 m
1,90 m
1,90 m
Effective tax rate
23,78%
23,78%
19,80%
19,80%
Other operating expenses
-
-
-
-
Net income
7,52 m
7,52 m
7,70 m
7,70 m
Net profit margin
53,16%
53,16%
42,35%
42,35%
Earnings per share
-
-
-
-
Interest and investment income
3,15 m
3,15 m
2,93 m
2,93 m
Interest expense
-
-
-
-
Net interest expenses
3,15 m
3,15 m
2,93 m
2,93 m
Depreciation and amortization charges
-
-
-
-
EBITDA
5,45 m
5,45 m
5,58 m
5,58 m
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer